ABBOTT LABORATORIES — Director's Dealing 2012

Sep 11, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2012-09-07

Reporting Person: Landgraf John C (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-09-07	Common shares without par value	M	31508	$53.19	Acquired	125720	Direct
2012-09-07	Common shares without par value	M	7057	$53.12	Acquired	132777	Direct
2012-09-07	Common shares without par value	F	33928	$66.92	Disposed	98849	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-09-07	Option (right to buy)	$53.19	M	13588	Disposed	2014-08-02	Common shares (13588)	Direct
2012-09-07	Option (right to buy)	$53.19	M	17920	Disposed	2014-02-19	Common shares (17920)	Direct
2012-09-07	Option (right to buy)	$53.12	M	7057	Disposed	2014-02-19	Common shares (7057)	Direct
2012-09-07	Option (right to buy)	$66.92	A	11956	Acquired	2014-08-02	Common shares (11956)	Direct
2012-09-07	Option (right to buy)	$66.92	A	21972	Acquired	2014-02-19	Common shares (21972)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	18040	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of September 7, 2012.

F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.